BackgroundIn 2005, the United States Preventive Services Task Force (USPSTF) released guidelines which outlined specific family history patterns associated with an increased risk for BRCA1/2 mutations, and recommended at-risk individuals be referred for genetic counseling and evaluation for BRCA testing. The purpose of this study was to assess the prevalence of individuals with a USPSTF increased-risk family history pattern, the frequency with which specific patterns were met, and resulting healthcare actions among women from the Henry Ford Health System.MethodsAs part of a study evaluating ovarian cancer risk perception and screening, 2,524 randomly selected participants completed a detailed interview (response rate 76%) from an initial el...
Force (USPSTF) recommendation on genetic risk assessment and BRCA mutation testing for breast and ov...
© 2019 American Medical Association. All rights reserved. Importance: Potentially harmful mutations ...
Mutations in BRCA1 and BRCA2 cause tumor development in Hereditary Breast and Ovarian Cancer syndrom...
BackgroundEvidence shows underutilization of cancer genetics services. To explore the reasons behind...
Women with a documented deleterious mutation in BRCA1 or BRCA2 are at substantially elevated risk fo...
Background: Approximately 1/300 individuals in the general population are at risk for hereditary bre...
Background BRCA1 and BRCA2 mutations confer a substantial breast risk of developing ...
ImportancePotentially harmful mutations of the breast cancer susceptibility 1 and 2 genes (BRCA1/2) ...
Background: This nationwide study assessed the impact of nationally agreed cancer genetics guideline...
Mutations in the BRCA1 or BRCA2 genes are associated with increased risks for breast, ovarian, and s...
Approved May 2017 by the faculty of UMKC in partial fulfillment of the requirements for the degree ...
Importance: Potentially harmful mutations of the breast cancer susceptibility 1 and 2 genes (BRCA1/2...
Introduction BRCA mutation testing has been used for screening women at high risk of breast and ovar...
Genetic counseling and BRCA1/BRCA2 genes testing are routinely offered in a clinical setting. Howeve...
Hereditary breast and ovarian cancer (HBOC) is an inherited cancer syndrome that is associated with ...
Force (USPSTF) recommendation on genetic risk assessment and BRCA mutation testing for breast and ov...
© 2019 American Medical Association. All rights reserved. Importance: Potentially harmful mutations ...
Mutations in BRCA1 and BRCA2 cause tumor development in Hereditary Breast and Ovarian Cancer syndrom...
BackgroundEvidence shows underutilization of cancer genetics services. To explore the reasons behind...
Women with a documented deleterious mutation in BRCA1 or BRCA2 are at substantially elevated risk fo...
Background: Approximately 1/300 individuals in the general population are at risk for hereditary bre...
Background BRCA1 and BRCA2 mutations confer a substantial breast risk of developing ...
ImportancePotentially harmful mutations of the breast cancer susceptibility 1 and 2 genes (BRCA1/2) ...
Background: This nationwide study assessed the impact of nationally agreed cancer genetics guideline...
Mutations in the BRCA1 or BRCA2 genes are associated with increased risks for breast, ovarian, and s...
Approved May 2017 by the faculty of UMKC in partial fulfillment of the requirements for the degree ...
Importance: Potentially harmful mutations of the breast cancer susceptibility 1 and 2 genes (BRCA1/2...
Introduction BRCA mutation testing has been used for screening women at high risk of breast and ovar...
Genetic counseling and BRCA1/BRCA2 genes testing are routinely offered in a clinical setting. Howeve...
Hereditary breast and ovarian cancer (HBOC) is an inherited cancer syndrome that is associated with ...
Force (USPSTF) recommendation on genetic risk assessment and BRCA mutation testing for breast and ov...
© 2019 American Medical Association. All rights reserved. Importance: Potentially harmful mutations ...
Mutations in BRCA1 and BRCA2 cause tumor development in Hereditary Breast and Ovarian Cancer syndrom...